Cargando…

Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux

Venous thromboembolism (VTE) is a frequent complication among acutely ill medical patients hospitalized for congestive heart failure, acute respiratory insufficiency, rheumatologic disorders, and acute infectious and/or inflammatory diseases. Based on robust data from randomized controlled studies a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Nisio, Marcello, Porreca, Ettore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782407/ https://www.ncbi.nlm.nih.gov/pubmed/24068866 http://dx.doi.org/10.2147/DDDT.S38042

Ejemplares similares

Inflammasome Signaling, Thromboinflammation, and Venous Thromboembolism
por: Potere, Nicola, et al.
Publicado: (2023)

Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis
por: Porfidia, Angelo, et al.
Publicado: (2020)

Study on the safety and effectiveness of low-dose vs. regular-dose fondaparinux in preventing venous thromboembolism prophylaxis following total knee arthroplasty
por: Chen, Ping-bo, et al.
Publicado: (2023)

Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery
por: Bergqvist, David
Publicado: (2006)

Fondaparınux Versus Nadroparın for Preventıon of Venous Thromboembolısm After Electıve Hıp and Knee Arthroplasty()
por: Argun, Mahmut, et al.
Publicado: (2013)

Fondaparinux Pre-, Peri-, and/or Postpartum for the Prophylaxis/Treatment of Venous Thromboembolism (FondaPPP)
por: Dempfle, Carl-Erik, et al.
Publicado: (2021)

Fondaparinux vs. enoxaparin for the prevention of venous thromboembolism after total hip replacement: A meta-analysis
por: Dong, Wen-Jun, et al.
Publicado: (2016)

Prediction of venous thromboembolism in patients with lower-limb immobilization
por: Di Nisio, Marcello, et al.
Publicado: (2020)

Safety of fondaparinux to prevent venous thromboembolism in Japanese patients undergoing colorectal cancer surgery: a multicenter study
por: Hata, Taishi, et al.
Publicado: (2014)

Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux in women at risk after cesarean section
por: Kawaguchi, Ryuji, et al.
Publicado: (2017)

Efficacy and safety of fondaparinux in preventing venous thromboembolism in Chinese cancer patients: a single-arm, multicenter, retrospective study
por: Wang, Lei, et al.
Publicado: (2023)

Use of Fondaparinux Following Elective Lumbar Spine Surgery Is Associated With a Reduction in Symptomatic Venous Thromboembolism
por: Fourman, Mitchell S., et al.
Publicado: (2019)

Effectiveness of Fondaparinux in the Japanese Population with Acute Venous Thromboembolism -A Study Comparing Patients with and without Cancer-
por: Yamashita, Asami, et al.
Publicado: (2022)

Betrixaban for prevention of venous thromboembolism in acute medically ill patients
por: Beyer-Westendorf, Jan, et al.
Publicado: (2018)

Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation
por: Potere, Nicola, et al.
Publicado: (2020)

The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
por: Spyropoulos, Alex C, et al.
Publicado: (2008)

A systematic review of clinical practice guidelines on the use of low molecular weight heparin and fondaparinux for the treatment and prevention of venous thromboembolism: Implications for research and policy decision-making
por: Johnston, Amy, et al.
Publicado: (2018)

An update on prevention of venous thromboembolism in hospitalized acutely ill medical patients
por: Samama, Meyer Michel, et al.
Publicado: (2006)

Low dose compared to variable dose Warfarin and to Fondaparinux as prophylaxis for thromboembolism after elective hip or knee replacement surgery; a randomized, prospective study
por: Bern, Murray M., et al.
Publicado: (2015)

Fondaparinux sodium and low molecular weight heparin for venous thromboembolism prophylaxis in Chinese patients with major orthopedic surgery or trauma: a real-world study
por: Fu, Donglin, et al.
Publicado: (2022)

Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study
por: van Es, Nick, et al.
Publicado: (2017)

The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018)

Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
por: Abdulla, Aliya, et al.
Publicado: (2023)

Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19
por: Zermatten, Maxime G., et al.
Publicado: (2020)

High-dose versus low-dose venous thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis
por: Valeriani, Emanuele, et al.
Publicado: (2022)

Plasma concentrations of D-dimer and outcome of in vitro fertilization
por: Di Nisio, Marcello, et al.
Publicado: (2014)

Low-Dose Rivaroxaban to Prevent Recurrences of Venous Thromboembolism in Cancer: A Real-Life Experience with a Focus on Female Patients
por: Santini, Paolo, et al.
Publicado: (2023)

Occurrence rates and risk factors of in-hospital venous thromboembolism, major bleeding, and death in patients receiving fondaparinux after orthopedic surgery or trauma surgery
por: Ding, Ya, et al.
Publicado: (2023)

Fondaparinux-associated Thrombocytopenia
por: Malik, Jahanzeb, et al.
Publicado: (2021)

Safety and Effectiveness of Reduced Dose Versus Standard Dose Enoxaparin Venous Thromboembolism Prophylaxis in Underweight Medically Ill Patients
por: Nemeth, Abigail, et al.
Publicado: (2022)

A case of probable bemiparin-induced HIT type II managed with low-dose fondaparinux
por: Koufakis, T, et al.
Publicado: (2015)

Primary prevention of venous thromboembolism in elderly medical patients
por: Lacut, Karine, et al.
Publicado: (2008)

Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis
por: Lipardi, Concetta, et al.
Publicado: (2021)

Clinical utility of apixaban in the prevention and treatment of venous thromboembolism: current evidence
por: Zalpour, Ali, et al.
Publicado: (2014)

A systematic approach to venous thromboembolism prevention: a focus on UK experience
por: Clapham, Rachel E., et al.
Publicado: (2022)

Prevention and treatment of venous thromboembolism
por: Casadei, Barbara, et al.
Publicado: (2020)

Epidemiology and prevention of venous thromboembolism
por: Lutsey, Pamela L., et al.
Publicado: (2022)

When Will Fondaparinux Induce Thrombocytopenia?
por: Chen, Li-Yu, et al.
Publicado: (2022)

Design and Synthesis of Neutralizable Fondaparinux
por: Zhang, Liangwei, et al.
Publicado: (2022)

Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey
por: Cook, Deborah, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_6apt0vkfvutmp9lh96tkfo6a0k